About the role
Company Overview
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.
Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer.
This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts.
Summary
We are seeking a Global Program Operations Head (GPOH), reporting into the Vice President, Clinical Operations, to lead the strategic and operational execution of a portfolio of clinical trials within a designated disease area. This role partners cross-functionally with Clinical, Medical, Regulatory, and Operational Excellence to ensure programs are aligned with corporate goals, regulatory requirements, and operational feasibility.
You will drive program-level strategy, oversee trial execution, and manage Contract Research Organizations (CROs) and external vendors, ensuring delivery against timelines, budgets, and quality expectations. Additionally, you will lead and develop a high-performing clinical operations team while supporting governance, risk management, and inspection readiness in a fast-paced biotech environment.
Your Role
- Oversee the strategic and operational execution of a portfolio of clinical trials within a designated disease area
- Ensure alignment with corporate goals and regulatory standards
- Represent Global Clinical Operations in Global Program Teams (GPTs) and sub-teams, contributing to program-level strategy and operational planning
- Collaborate with Medical and Regulatory Directors to ensure clinical strategies are scientifically sound, meet regulatory requirements, and are operationally feasible
- Partner with Operational Excellence & Clinical Compliance to align on risk assessment, trial- and site management metrics, KPIs, and KRIs
- Define and implement outsourcing strategies in partnership with the VP of Global Clinical Operations and Head of Clinical Sourcing & Contracting
- Lead the selection, negotiation, contracting, and performance oversight of CROs and external vendors
- Monitor trial progress and key deliverables, guiding Clinical Trial Teams (CTTs) in execution planning, issue resolution, and risk mitigation
- Manage program and trial budgets, ensuring accurate forecasting, cost control, and financial accountability
- Track CRO/ vendor performance using metrics, KPIs, KRIs and participate in governance meetings to address escalated issues and drive continuous improvement
- Provide regular updates on trial progress to internal governance bodies, including GPT and Executive Leadership Team
- Support inspection readiness activities and represent the organization during Health Authority inspections
- Provide leadership, coaching, and performance management to Clinical Trial Leaders (CTLs), Clinical Contract Managers (CTMs), Clinical Trial Specialists (CTSs), and Site Management Leader (SMLs)
- Set clear objectives, deliver ongoing feedback, and develop tailored development plans to support team growth and capability building
- Oversee hiring, onboarding, and training of new team members, fostering a culture of operational excellence and continuous learning
What You Bring
- 12+ years of trial management experience with 7+ years in leadership position
- Bachelor’s degree in Life Sciences, Pharmacy or related field (required). Advanced degree, e.g., MS, PharmD, PhD, MBA (preferred).
- Significant experience working in global clinical development organization
- Experience in Oncology development (preferred)
- Direct experience with health authority inspections (FDA, EMA, MHRA, etc.) incl. sponsor GCP inspections
- Significant experience in outsourcin
Aplyr's read
Tango Therapeutics pioneers precision cancer treatments by exploiting genetic vulnerabilities, attracting specialists in oncology, biostatistics, and regulatory affairs.
What's promising
- •Focus on precision medicine offers innovative cancer treatment options.
- •Recent expansion in clinical and regulatory roles indicates growth and development.
- •Strong emphasis on genetic research provides cutting-edge therapeutic opportunities.
What to watch
- •Biotechnology sector faces high research and development costs.
- •Success depends on navigating complex regulatory environments.
- •Competition from larger biotech firms could impact market share.
Why Tango Therapeutics
- •Targets genetic vulnerabilities in tumors for precision treatment.
- •Diverse roles in oncology and regulatory affairs highlight specialized focus.
- •Commitment to cutting-edge genetic research differentiates from traditional approaches.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Tango Therapeutics
Tango Therapeutics is a biotechnology company focused on developing precision medicines for cancer by targeting specific genetic vulnerabilities in tumors.
Similar roles
Zonal Account Manager
Johnson & Johnson
Commercial Post Quantum Cryptography Director
Booz Allen Hamilton
Manager - Sourcing and Procurement
Verisign
Materials Coordinator, 3rd shift, 10:00 pm - 6:00am $23.18/hr.+*
C.H. Guenther
Business Operations Intern
Payoneer
Sr Director - Supply Chain Modernization
McKesson